These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36539128)

  • 1. THE CORRELATION BETWEEN SERUM HOMOCYSTEINE LEVEL AND PARKINSON'S DISEASE DISABILITY.
    Taher Y; Natheer M; Majdal H
    Georgian Med News; 2022 Oct; (331):36-41. PubMed ID: 36539128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital.
    Ojo OO; Oladipo OO; Ojini FI; Sanya EO; Danesi MA; Okubadejo NU
    West Afr J Med; 2011; 30(5):319-24. PubMed ID: 22752818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between blood lipid, serum cystatin C, and homocysteine levels in patients with Parkinson's disease.
    Li J; Gu C; Zhu M; Li D; Chen L; Zhu X
    Psychogeriatrics; 2020 Mar; 20(2):180-188. PubMed ID: 31828903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum homocysteine and physical exercise in patients with Parkinson's disease.
    Nascimento CM; Stella F; Garlipp CR; Santos RF; Gobbi S; Gobbi LT
    Psychogeriatrics; 2011 Jun; 11(2):105-12. PubMed ID: 21707858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of homocysteine, folate, and white matter hyperintensities in Parkinson's patients with different motor phenotypes.
    Shen Y; Dong ZF; Pan PL; Xu G; Huang JY; Liu CF
    Neurol Sci; 2019 Sep; 40(9):1855-1863. PubMed ID: 31055730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of homocysteine with ventricular dilatation and brain atrophy in Parkinson's disease.
    Sapkota S; Gee M; Sabino J; Emery D; Camicioli R
    Mov Disord; 2014 Mar; 29(3):368-74. PubMed ID: 24395213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
    Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia influenced malnutrition in Parkinson's disease patients.
    Tomic S; Pekic V; Popijac Z; Pucic T; Vinkovic MP; Kuric TG; Popovic Z
    Neurol Sci; 2018 Oct; 39(10):1691-1695. PubMed ID: 29961201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between homocysteine and third ventricle dilatation, mesencephalic area atrophy in Parkinson's disease with cognitive impairment.
    Fu XY; Zhang YC; Ding CW; Yang M; Song X; Wang CS; Chen XF; Zhang Y; Sheng YJ; Mao P; Mao CJ; Liu CF
    J Clin Neurosci; 2021 Aug; 90():273-278. PubMed ID: 34275563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression features of serum Cystatin C and homocysteine of Parkinson's disease with mild cognitive dysfunction.
    Chen WW; Cheng X; Zhang X; Zhang QS; Sun HQ; Huang WJ; Xie ZY
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):2957-63. PubMed ID: 26367713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Quantification and Visualization of Homocysteine, Cysteine, and Glutathione in Alzheimer's and Parkinson's Disease Model Tissues.
    Yin G; Gan Y; Jiang H; Yu T; Liu M; Zhang Y; Li H; Yin P; Yao S
    Anal Chem; 2021 Jul; 93(28):9878-9886. PubMed ID: 34229430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex Differences in the Level of Homocysteine in Alzheimer's Disease and Parkinson's Disease Patients: A Meta-Analysis.
    Nguyen VP; Collins AE; Hickey JP; Pfeifer JA; Kalisch BE
    Brain Sci; 2023 Jan; 13(1):. PubMed ID: 36672134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients.
    Camicioli RM; Bouchard TP; Somerville MJ
    Mov Disord; 2009 Jan; 24(2):176-82. PubMed ID: 18951534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions.
    Zoccolella S; Lamberti P; Iliceto G; Diroma C; Armenise E; Defazio G; Lamberti SV; Fraddosio A; de Mari M; Livrea P
    Clin Chem Lab Med; 2005; 43(10):1107-10. PubMed ID: 16197306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.
    Rodriguez-Oroz MC; Lage PM; Sanchez-Mut J; Lamet I; Pagonabarraga J; Toledo JB; García-Garcia D; Clavero P; Samaranch L; Irurzun C; Matsubara JM; Irigoien J; Bescos E; Kulisevsky J; Pérez-Tur J; Obeso JA
    Mov Disord; 2009 Jul; 24(10):1437-44. PubMed ID: 19452554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of Plasma Homocysteine and Minor Hallucinations in Parkinson's Disease: A Cross-Sectional Study.
    Zhong M; Zhu S; Gu R; Wang Y; Jiang Y; Bai Y; Jiang X; Shen B; Yan J; Pan Y; Zhu J; Zhang L
    Behav Neurol; 2022; 2022():4797861. PubMed ID: 35295686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of MRI white matter hyperintensities on dementia in Parkinson's disease in relation to the homocysteine level and other vascular risk factors.
    Sławek J; Roszmann A; Robowski P; Dubaniewicz M; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Kurzawski M; Bandurski T; Białecka M
    Neurodegener Dis; 2013; 12(1):1-12. PubMed ID: 22831964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma homocysteine, folate and vitamin B12 levels in Parkinson's disease in China: A meta-analysis.
    Dong B; Wu R
    Clin Neurol Neurosurg; 2020 Jan; 188():105587. PubMed ID: 31733593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of homocysteine (hcy) on dementia in Parkinson's disease (PD).
    Song IU; Kim JS; Park IS; Kim YD; Cho HJ; Chung SW; Lee KS
    Arch Gerontol Geriatr; 2013; 57(3):288-91. PubMed ID: 23706974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of homocysteine and C-reactive protein predicts the outcomes of Chinese patients with Parkinson's disease and vascular parkinsonism.
    Zhang L; Yan J; Xu Y; Long L; Zhu C; Chen X; Jiang Y; Yang L; Bian L; Wang Q
    PLoS One; 2011 Apr; 6(4):e19333. PubMed ID: 21556377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.